Inotiv, Inc. (NasdaqCM:NOTV) acquired Orient BioResource Center, Inc. from ORIENT BIO Inc. (KOSE:A002630) for $51.3 million in November 2021. As per the terms of the transaction, Inotiv shall pay $28.3 million in cash, which includes an adjustment for net working capital and cash balances and 0.7 million Inotiv common shares having a value of $23 million. In the fiscal year of 2021, Orient BioResource Center reported a total revenues of $23 million.

Inotiv, Inc. (NasdaqCM:NOTV) completed the acquisition of Orient BioResource Center, Inc. from ORIENT BIO Inc. (KOSE:A002630) in November 2021.